Insulin resistance is closely related to intramyocellular lipid (IMCL) accumulation, and both are associated with increasing age. It remains to be determined to what extent perturbations in IMCL metabolism are related to the ageing process per se. On two separate occasions wholebody and muscle insulin sensitivity (euglycaemic hyperinsulinaemic clamp with 2-deoxyglucose) and fat utilisation during 1 h of exercise at 50% VO 2 max ([U-
The global prevalence of type 2 diabetes is most apparent in older people (1) , and it is estimated that the number of people over 65 years of age with diabetes will have increased 4.5 fold by 2050 (2) . Gaining mechanistic insight of age related insulin resistance and strategies to improve insulin sensitivity with age are clearly warranted. Although ageing is associated with insulin resistance, age per se does not appear to cause insulin resistance (3, 4, 5) . Several factors that likely contribute to age related insulin resistance include increased abdominal adiposity and reduced physical activity (3, 4) , along with declines in muscle mass (6, 7) . Of note, intramyocellular lipid (IMCL) accumulates with age, particularly in subsarcolemmal (SSL) regions (8) , and has been strongly associated with insulin resistance (9, 10, 11, 12) . Indeed, SSL lipid accumulation has been linked to the accumulation of metabolites, such as diacylglycerol (DAG) and ceramide, thought by some (13, 14, 15) , but not others (16) , to contribute to impaired insulin-stimulated muscle glucose uptake.
Nevertheless, it remains contentious as to which factors associated with age influence IMCL accumulation.
The accumulation of IMCL and associated metabolites likely result from an imbalance between muscle lipid delivery and oxidation. Indeed, studies have demonstrated reduced free fatty acid (FFA) oxidation in older people compared to young, despite whole-body lipolysis and plasma FFA availability being greater at rest and during exercise at the same absolute and relative intensities (17, 18) . Linked to this, several studies have suggested age related blunting of FFA oxidation and increased IMCL accumulation are a result of reduced muscle mitochondrial content (8) and function (3, 19, 20) with age. However, increased adiposity and reduced habitual levels of physical activity also affect FFA flux and oxidation in older individuals (21) , and studies to date have not controlled for these factors when investigating changes in muscle IMCL metabolism with age. Therefore, we investigated the effect of 4 ageing on whole-body and skeletal muscle lipid metabolism, with parallel characterization of muscle insulin sensitivity, in lean young and older individuals matched for estimated habitual physical activity levels and body composition. To determine the effect of adiposity and reduced physical activity on the ageing process, the older lean individuals were also compared to a group of older overweight individuals matched for lean mass. We hypothesized that an age-associated imbalance between FFA delivery and oxidation in skeletal muscle during exercise would only be observed in older overweight individuals, which would manifest as reduced IMCL oxidation and increased IMCL storage, particularly in the SSL region, and be associated with skeletal muscle insulin resistance. and the workload that would elicit 50% VO 2 max, which was confirmed in a familiarization visit at least 3 days later.
RESEARCH DESIGN AND METHODS

Subjects
Experimental Protocol
Subjects attended the laboratory on two occasions separated by at least 1 week. On the first occasion they arrived at 0800 after an overnight fast, having abstained from exercise and alcohol for the previous 48 hours, in order to determine their body composition and insulin sensitivity. Trunk, leg and arm composition using standardized regions were analyzed by a single operator using dual energy x-ray absorptiometry (DEXA; Lunar Prodigy, GE On the second experimental visit, blood samples were obtained before and every 10 min by LC-MS-MS (Quattro Ultima, Micromass Ltd, UK; 34, 35). Peak areas were normalised to the internal standard and converted to absolute concentrations using a standard curve specific for each species. A further portion of muscle powder was also used for the determination of muscle creatine, phosphocreatine, glycogen, lactate, and acetylcarnitine as previously described (36) .
Calculations
Insulin sensitivity index (SI Clamp ) was calculated using the equation of Matsuda and DeFronzo
where steady-state (120-180 min) glucose disposal (M) is normalized for steady-state blood glucose concentration (G; mmol/L) and the difference between fasting and steady-state plasma insulin concentrations (∆I; mU/L). Indirect calorimetry calculations both at rest and during exercise were performed according to nonprotein stoichiometric equations (37) and normalised to lean body mass (DEXA). The rate of appearance (Ra), disappearance (Rd), and oxidation of palmitate during the final 10 min of exercise were used to calculate total plasma FFA kinetics by dividing the fractional contribution of plasma palmitate to total plasma FFA concentration as previously described (38) . The contribution of other fat sources was calculated by subtracting plasma FFA oxidation from total fat oxidation calculated via indirect calorimetry.
Statistical Analysis
Differences between groups at baseline, and within and between groups during exercise, were analyzed using a one-and two-way ANOVA, respectively (GraphPad Prism 6.0, GraphPad Software Inc, USA). When a significant main effect was observed, Tukey's and Sidak's posthoc test was performed, respectively, to identify individual differences. Statistical significance was set at P<0.05, and all values are presented as means ± SEM.
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RESULTS
Subject characteristics
In line with the inclusion criteria OL and YL had a similar body composition. However, OO had greater trunk, arm and leg fat masses compared with OL and YL subjects, but similar whole-body, arm and leg fat free mass (Table 1) . Furthermore, self-reported levels of habitual physical activity were similar between OL and YL, but less in OO compared to OL. Both OL and OO had similar absolute (mL/min) and relative (mL·kg lbm -1 ·min -1 ) VO 2 max but these were less than in YL, as were the corresponding absolute workload and heart rate at 50% VO 2 max.
Skeletal muscle insulin sensitivity and lipid metabolite content
Steady-state serum insulin and glucose disposal during the euglycaemic hyperinsulinaemic clamp for OL, YL, and OO were (119.6 ± 7.0, 117.7 ± 7.8, and 137.5 ± 4.3 mU/L) and (57.8 ± 5.6, 65.1 ± 5.6, and 41.6 ± 5.2 µmol·kg lbm -1 ·min -1 ; P<0.01 OL and YL vs. OO),
respectively. As such, OL and YL had similar SI Clamp that were 57% (P<0.05) and 86% (P<0.01) greater than OO, respectively ( Figure 1A) . Furthermore, muscle 2DG6P accumulation during the clamp was not different between OL and YL, but was less than half that of YL in OO (P<0.01; Figure 1B) , and OL and YL had similar steady-state plasma 2DG concentrations during the clamp, which were less than OO (50.0 ± 1.9 and 48.8 ± 2.2 vs. 72.6 ± 2.2 µmol/L, respectively; P<0.05; Figure 1C ). Insulin-stimulated resting energy expenditure increased by more than 10% in both OL (P<0.01) and YL (P<0.05), but did not change in OO (P=1.0; Figure 1D ). There were no differences in muscle DAG species between groups with the exception of diC18:1, which was lower in OL and YL compared to OO (both P<0.05; Figure 2A ). Similarly most muscle ceramide species did not differ except C20:0, which was lower in YL compared to OO (P<0.01; Figure 2B ).
Whole body substrate metabolism during exercise
Whole body energy expenditure during the last 10 min of 1 h of exercise at 50% VO 2 max was lower in OL and OO compared to YL (both P<0.05; Figure 3A ), but the relative contribution from total fat oxidation to energy expenditure was similar (42.4 ± 3.1, 40.1 ± 4.6 and 43.9 ± 6.5%, respectively). Nevertheless, the oxidation of fat from sources other than plasma FFA (i.e. predominantly from IMCL) was almost 3-fold lower in OL and OO compared to YL (both P<0.05; Figure 3A ), such that the relative contribution of these sources to total fat oxidation was around half that of YL (38.7 ± 7.7 and 45.0 ± 7.9 vs. 71.9 ± 3.1 %, respectively; P<0.01; Figure 3A Figure 3B ). In contrast, whereas the percentage of plasma FFA Rd oxidized was similar between OL and YL (54.4 ± 5.9 and 52.7 ± 3.4%, respectively; Figure 3C ), it was lower in OO (42.2 ± 1.2%) compared to OL (P<0.05) and YL (P=0.07; Figure 3C ).
From similar baseline concentrations, plasma norepinephrine increased to a similar steadystate in OL and OO throughout 1 h of exercise, and was around 1.5-fold greater than the steady-state concentration achieved in YL (both P<0.05 respectively; Figure 3D ). However, there were no differences between groups in baseline or steady-state plasma epinephrine 
IMCL and skeletal muscle oxidative metabolism during exercise
The area of SSL region covered by LD was similar between OL and YL at rest and did not change during exercise ( Figure 4A ). However, SSL area covered by LD in OO was almost 3-fold greater at rest compared with YL (P<0.05) and increased during exercise (P<0.05), such that post-exercise it was greater than both OL (P<0.05) and YL (P<0.01; Figure 4A ). This was predominantly due to a 25% increase in average SSL LD size in OO (P=0.05; Figure   4B ). In contrast, exercise caused a decrease (P<0.01) in both the number of IMF LD (0.024 ± 0.001 to 0.017 ± 0.003, 0.022 ± 0.003 to 0.015 ± 0.002, and 0.023 ± 0.03 to 0.018 ± 0.003LD/µm 2 for OL, YL and OO, respectively) and area covered by LD ( Figure 4C ). The latter was isolated to a 40% reduction in IMF area covered by LD in YL (0.05; Figure 4C ).
Average IMF LD size was 45% greater in OO compared to OL and YL post-exercise (both P<0.01; Figure 4D ).
Resting skeletal muscle glycogen ( Figure 5A ), phosphocreatine ( Figure 5B), and lactate ( Figure 5C ) content was similar between OL and YL and did not change measurably during exercise, whereas acetylcarnitine content increased during exercise by around 7 (P<0.001) and 3 fold (P<0.05), respectively. However, resting muscle glycogen and phosphocreatine content were lower (P<0.05) and muscle lactate content more than doubled during exercise (P<0.05) in OO. Nevertheless, there were no significant differences in maximal CS (116. 
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Skeletal muscle gene expression
The relative expression of 12 skeletal muscle transcripts involved in fatty oxidation and IMCL turnover are presented in Table 2 . HADHB and PLIN2 expression were greater in OL compared to YL (P<0.05), whereas ACACB, SPTLC1, and DGKD expression were lower in YL compared to OO (all P<0.05). Furthermore, PLIN2 gene expression was greater in OL vs.
OO (P<0.05) respectively.
DISCUSSION
Insulin resistance is closely related to IMCL accumulation, and both are associated with increasing age. However, it remains to be determined to what extent perturbations in IMCL metabolism are related to the ageing process per se or secondary to age-related changes in lifestyle. Thus, by matching young and older volunteers for body composition and selfreported habitual physical activity levels the present study demonstrated that lean older individuals display comparable IMCL content and insulin sensitivity to their younger counterparts. On the other hand, ageing per se appeared to cause an exacerbated lipolytic response to exercise due, at least in part, to an increased sympathetic response. Coupled with increased adiposity and reduced habitual physical activity levels in an age-matched group this resulted in SSL IMCL accumulation, and may mechanistically help explain the association between increased IMCL and skeletal muscle insulin resistance in older individuals.
In line with several studies that suggest ageing per se does not cause insulin resistance (3, 4, 5) , there was no difference in whole-body glucose disposal, skeletal muscle 2DG6P accumulation, or the energy expenditure response during a euglycaemic hyperinsulinaemic clamp between old and young individuals matched for body composition and self-reported physical activity in the present study. Furthermore, the finding that whole-body and skeletal muscle insulin action was reduced in old overweight individuals with a similar lean body mass but lower self-reported physical activity supports the notion that lifestyle factors are more influential in the development of age-related insulin resistance (3, 4, 5, 39, 40, 41) . A possible link between these factors and reduced skeletal muscle insulin sensitivity is the accumulation of SSL IMCL (9, 10) and associated lipid metabolites such as DAG and ceramide (13, 14, 15) . Indeed, whereas there was no difference in SSL IMCL between lean Page 14 of 31 Diabetes old and young, SSL IMCL was more than 2-fold higher in the older overweight individuals, which is in agreement with a 2 and 3-fold greater content observed in lean sedentary older individuals (8) and type 2 diabetes (9), respectively. However, although the skeletal muscle content of the predominant DAG and ceramide species were not different between lean old and young they were also not greater in old overweight, with the exception of diC18:1 DAG and C20:0 ceramide. Indeed, total muscle DAG and ceramide do not correlate well with insulin sensitivity but specific lipid species, particularly sarcolemmal saturated DAG, may influence insulin action (42) .
Why IMCL accumulates, particularly in the SSL region, is not clear, but several studies have demonstrated reduced FFA oxidation in older individuals despite increased whole body lipolysis and FFA availability compared to young at rest and during exercise (17, 18) . Indeed, although the relative contribution of fat oxidation to total energy expenditure during exercise was not different between the young and old groups of the present study, there was an elevated plasma norepinephrine, FFA Ra, and FFA Rd response to exercise at the same relative intensity observed in both the lean and overweight older individuals, suggesting an effect of age per se on whole body responses. This would fit with previous reports that age associated increments in norepinephrine are independent of habitual physical activity and likely due increased sympathetic activity rather than reduced norepinephrine clearance (43) .
As a consequence, the relative contribution of IMCL to fat oxidation was reduced in both old lean and overweight compared to young individuals. This is remarkable given there was presumably a greater lipolytic stimulus to IMCL by norepinephrine in the older individuals (44, 45) , and would suggest a potent inhibitory effect of plasma derived FFA or a blunted contraction induced IMCL hydrolysis. Furthermore, a novel finding of the present study was that, assuming similar rates of adipose tissue FFA re-esterification (where FFA released from In addition to reduced energy expenditure, such as observed during insulin-stimulated conditions of the present study, several mechanisms may explain the apparent inability of skeletal muscle of older overweight men to oxidize excess FFA delivery. For example, it has been suggested that aging is associated with impaired in vivo (19) and in vitro (3, 20) skeletal muscle mitochondrial ATP production, as well as a reduction in mitochondrial content (8), independently of adiposity. However, there was no difference in skeletal muscle maximal CS activity, maximal and relative CPT1 activity, or phosphocreatine, glycogen, lactate, and acetylcarnitine metabolism during exercise between the lean old and young participants in the present study, all of which are markers of in vivo muscle oxidative capacity. On the other hand, the disparity between old lean and old overweight participants in the ability to oxidize excess fatty acids may be due to differences in partitioning of skeletal muscle lipid and a diversion of fatty acids from oxidation towards synthesis of IMCL and other lipid species.
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For example, older lean individuals had a greater mRNA expression of perilipin 2 (PLIN2), a lipid droplet bound protein involved IMCL hydrolysis, and β-hydroxyacyl-CoA dehydrogenase (HADHB), an intramitochondrial enzyme that catalyses a rate-limiting step in β-oxidation, whereas old overweight had greater mRNA expression of acetyl-CoA carboxylase 2 (ACACB), which produces malonyl-CoA and inhibits CPT1, the rate limiting step for fatty acid entry into mitochondria. The PLIN2 expression in particular would fit previous reports in overweight individuals of impaired IMCL turnover and FFA release toward mitochondrial oxidation (44, 47) . Furthermore, old overweight had a greater expression of diacylglycerol kinase delta (DGKD), which phosphorylates diacylglycerol to produce phosphatidic acid, and serine palmitoyltransferase (SPTLC1), a rate-limiting step in ceramide synthesis, compared to young lean individuals. Both of these observations fit with the greater muscle content of some of the DAG and ceramide species in the present study. A similar gene expression pattern has also been previously observed in insulin resistant individuals (48), but how this translates into protein content/activity and whether it is cause or effect requires further investigation.
In conclusion, it is our assertion that increased IMCL (4, 8, 19) and reduced insulin sensitivity, mitochondrial capacity, and fat oxidation (3, 17, 18, 19, 20, 21, 49) often observed in older individuals are likely due to lifestyle factors rather than aging per se as commonly reported. However, age per se appears to increase the systemic sympathetic response to exercise and cause exacerbated adipose tissue lipolysis. Compounded by greater adiposity, the increased FA delivery appears to cause SSL IMCL accumulation in physically inactive older individuals. Thus, targeted strategies to reduce muscle lipid delivery and improve adipose tissue function may be warranted, particularly as physical inactivity appears to worsen the inability to suppress adipose tissue lipolysis in older individuals (50). Values represent mean ± SEM (n=7 
